Stock listing
ALNY Stock Price, News, Filings & Events — Alnylam Pharmaceuticals, Inc.
Selected listing: ALNY · NASDAQ · USD · US
This page tracks Alnylam Pharmaceuticals, Inc.'s ALNY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALNY:NASDAQ. ALNY:NASDAQ is the stock-level entry point for investors researching Alnylam Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alnylam Pharmaceuticals, Inc. is a public company traded under the ticker ALNY in the American market. The company has a market capitalization of approximately $36.3 billion. Alnylam focuses on developing innovative therapies based on RNA interference to treat genetic diseases.
- Ticker
- ALNY:NASDAQ
- Asset type
- Stock
- Market cap
- $31.61B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Alnylam Pharmaceuticals, Inc. ALNY:NASDAQ stock context
This page tracks Alnylam Pharmaceuticals, Inc.'s ALNY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALNY:NASDAQ. ALNY:NASDAQ is the stock-level entry point for investors researching Alnylam Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alnylam Pharmaceuticals, Inc. is a public company traded under the ticker ALNY in the American market. The company has a market capitalization of approximately $36.3 billion. Alnylam focuses on developing innovative therapies based on RNA interference to treat genetic diseases.
Latest news from Alnylam Pharmaceuticals, Inc.
Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026
August 24, 2026
Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress
July 30, 2026
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
July 16, 2026
Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease
July 15, 2026
Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
June 25, 2026
Alnylam Pharmaceuticals, Inc. earnings calls
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2025 Earnings Call
July 31, 2025 · Replay with transcript and chapters
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for ALNY:NASDAQ.
Alnylam Pharmaceuticals, Inc. company profile
View the public company page for Alnylam Pharmaceuticals, Inc. on 6ix.
Alnylam Pharmaceuticals, Inc. news
Read company news and market updates connected to Alnylam Pharmaceuticals, Inc..
Alnylam Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Alnylam Pharmaceuticals, Inc..
Alternate listings
DUL:GETTEX
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
A0CBCK:LSX
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
DUL:TRADEGATE
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
A1LN34:BMFBOVESPA
BR · BRL
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
ALNY:BMV
MX · MXN
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
A0CBCK:LS
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
DUL:XETR
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
0HD2:LSE
GB · USD
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
DUL:FWB
DE · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
1ALNY:MIL
IT · EUR
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
ALNY:BIVA
MX · MXN
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.
ALNY:BOATS
US · USD
Alternate listing for Alnylam Pharmaceuticals, Inc.; the primary context on this page is ALNY:NASDAQ.